Hydration Intervention to Decrease Side Effects Associated With GLP - 1 RA Therapy (NCT07641361)
Hydration Intervention to Address Dehydration Associated With Use of GLP-1 Based Medications
🩺 Plain-English Summary (8th-Grade Level)
This is a 17 - week study consisting of a one - week run - in period and a 16 - week intervention. The 16 - week pilot interventions aims to increase hydration in those beginning GLP - 1 RA therapy. Investigators aim to increase hydration to potentially decrease side effect severity, amount of side effects, and drug discontinuation associated with GLP - 1 RA therapy. The investigators are piloting to assess feasibility and preliminary efficacy of the intervention through examining participant retention, participant feedback, researcher and participant adherence to protocols, impact on hydration biomarkers, and participant reported GLP - 1 RA side effects.
Who can join: Review the eligibility criteria below.
Location: State University of New York at Buffalo, South Campus — Buffalo, New York
Age range: 18 Years to 60 Years
🧪 Interventions in This Study
- Hydration Plus (BEHAVIORAL)
- Control (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- State University of New York at Buffalo, South Campus — Buffalo, New York
📞 Contact the Study Coordinator
Phone: (716) 829-5820
Email: hkolpack@buffalo.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Obesity & Overweight
- Dietary Reversal of the Reprometabolic Syndrome — Aurora, Colorado
- Ultra-processed Food Consumption and Health Pilot Study — Baton Rouge, Louisiana
- Personalizing Financial Incentives — Salt Lake City, Utah
- A Study Comparing Continuous Glucose Monitoring Augmented Nutritional Counseling and Standard of Care Treatment Strategies in a Three-Month Nutrition Intervention — Gainesville, Florida
- Augmenting Primary Care-Based Obesity Management With the Nutu™ Digital Health Platform — Birmingham, Alabama
- Effect Of Whole or Skimmed Milk Greek Yogurt on Integrated Muscle Protein Synthesis, Glucose Homeostasis, and Cognition in Post-Menopausal Women — Little Rock, Arkansas
Explore by condition: All Obesity & Overweight clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.